Mcl-1 is an important mediator of paclitaxel resistance in breast cancer and other tumors and a critical prosurvival protein (Ding et al, 2008; Inuzuka et al, 2011; Wertz et al, 2011). Here, MCL1 is linked to breast carcinoma.